A systematic analysis of the complement pathways in patients with neuromyelitis optica indicates alteration but no activation during remission.
about
Change in autoantibody and cytokine responses during the evolution of neuromyelitis optica in patients with systemic lupus erythematosus: A preliminary studyA novel antibody against human properdin inhibits the alternative complement system and specifically detects properdin from blood samples.Plasma complement biomarkers distinguish multiple sclerosis and neuromyelitis optica spectrum disorder.Purified human C1-esterase inhibitor is safe in acute relapses of neuromyelitis optica.
P2860
A systematic analysis of the complement pathways in patients with neuromyelitis optica indicates alteration but no activation during remission.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
A systematic analysis of the c ...... o activation during remission.
@en
A systematic analysis of the c ...... o activation during remission.
@nl
type
label
A systematic analysis of the c ...... o activation during remission.
@en
A systematic analysis of the c ...... o activation during remission.
@nl
prefLabel
A systematic analysis of the c ...... o activation during remission.
@en
A systematic analysis of the c ...... o activation during remission.
@nl
P2093
P50
P1433
P1476
A systematic analysis of the c ...... no activation during remission
@en
P2093
Anita Trauninger
Csilla Rozsa
Dorottya Csuka
György Füst
Kornélia Eizler
Laszlo Bors
Zita Jobbágy
Zsolt Illes
Zsuzsanna Nagy
P304
P356
10.1016/J.MOLIMM.2013.09.010
P577
2013-10-26T00:00:00Z